The negative effect of antibiotics on RCC patients with immunotherapy: A systematic review and meta-analysis
BackgroundMicrobiome dysbiosis is considered a predictive biomarker of clinical response in renal cell carcinoma (RCC), which can be regulated by antibiotics (ATB). Multiple studies have shown that concomitant ATB administration has inhibitory effects on immunotherapy in RCC. This review aimed to as...
Main Authors: | Zhiqiang Luo, Siyuan Hao, Yuxuan Li, Lei Cheng, Xuedong Zhou, Emine Gulsen Gunes, Shiyu Liu, Jing Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-11-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.1065004/full |
Similar Items
-
RCC Real-World Data: Prognostic Factors and Risk Stratification in the Immunotherapy Era
by: Shira Sagie, et al.
Published: (2022-06-01) -
Current Status and Future Directions of Bacteria-Based Immunotherapy
by: Quan Tang, et al.
Published: (2022-06-01) -
Clearing up Clear Cell: Clarifying the Immuno-Oncology Treatment Landscape for Metastatic Clear Cell RCC
by: Sai Krishnaraya Doppalapudi, et al.
Published: (2021-08-01) -
A New Treatment Landscape for RCC: Association of the Human Microbiome with Improved Outcomes in RCC
by: Xuan-Mei Piao, et al.
Published: (2023-02-01) -
Antibiotic-Related Changes in Microbiome: The Hidden Villain behind Colorectal Carcinoma Immunotherapy Failure
by: Tsvetelina Velikova, et al.
Published: (2021-02-01)